Bone Marrow Aspirate Concentrate Versus Triamcinolone for Hip Osteoarthritis
This study is comparing two treatments for hip osteoarthritis: bone marrow aspirate concentrate (BMAC) and triamcinolone. BMAC involves taking a small amount of your bone marrow, concentrating it, and then injecting it into your hip. Triamcinolone is a steroid medication that will also be injected into your hip. Researchers want to see if one treatment is better at reducing pain and improving how well you can move your hip. They will measure this using a survey called the Western Ontario McMaster Universities Arthritis Index (WOMAC). You may be able to join if you are 18-75 years old and have hip osteoarthritis with a certain level of pain and joint damage. The study aims to enroll 100 participants, but the current recruitment status is unclear.
- Study design
- This is a randomized, single-blinded study with two groups, aiming to enroll 100 participants. You would be randomly assigned to receive either the bone marrow aspirate concentrate or triamcinolone.
- What's involved
- If you join, you will have a bone marrow aspiration (if in the BMAC group) and an injection into your hip. You will also complete surveys and have blood drawn at the beginning of the study.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your pain and function will be evaluated at 6 weeks, 3 months, 6 months, and 12 months after treatment.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Bone Marrow Aspirate Concentrate Versus Triamcinolone Injection For Hip Osteoarthritis
At a glance
Conditions
NCT04990128
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Cleveland Clinic Florida
Weston, Floridastudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- LEONARDO P OLIVEIRA, MD · PRINCIPAL_INVESTIGATOR · Cleveland Clinic Florida
- Carlos Higuera-Rueda, MD · STUDY_DIRECTOR · Cleveland Clinic Florida
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Western Ontario McMaster Universities Arthritis Index (WOMAC)Evaluate the change in pain and functional scores of a single bone marrow aspirate injection in comparison to triamcinolone in patients with hip osteoarthritis through validated patient reported outcomes scores at baseline to 6 weeks.
WOMAC Scores range from 0 to 96, with higher scores on the WOMAC indicate worse pain, stiffness, and functional limitations.
- Western Ontario McMaster Universities Arthritis Index (WOMAC)Evaluate the change in pain and functional scores of a single bone marrow aspirate injection in comparison to triamcinolone in patients with hip osteoarthritis through validated patient reported outcomes scores at baseline to 3 months.
WOMAC Scores range from 0 to 96, with higher scores on the WOMAC indicate worse pain, stiffness, and functional limitations.
- Western Ontario McMaster Universities Arthritis Index (WOMAC)Evaluate the change in pain and functional scores of a single bone marrow aspirate injection in comparison to triamcinolone in patients with hip osteoarthritis through validated patient reported outcomes scores at baseline to 6 months.
WOMAC Scores range from 0 to 96, with higher scores on the WOMAC indicate worse pain, stiffness, and functional limitations.
- Western Ontario McMaster Universities Arthritis Index (WOMAC)Evaluate the change in pain and functional scores of a single bone marrow aspirate injection in comparison to triamcinolone in patients with hip osteoarthritis through validated patient reported outcomes scores at baseline to 12 months.
WOMAC Scores range from 0 to 96, with higher scores on the WOMAC indicate worse pain, stiffness, and functional limitations.